Saturday 17 October 2026
Export SYK’s income statement to Excel — free account
Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
294.66
1.43
+0.49%
Follow SYK
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 16.51% | 15.20% | 15.08% | 14.04% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 7 | 5 | 4 | |
| 7.91% | 7.23% | 7.15% | 6.48% | ||
ROIC |
9.76% | 8.97% | 8.94% | 6.54% | |
Return on Tangible Assets |
31.89% | 30.59% | 29.95% | 29.34% | |
Average Days of Receivables |
52.88 | 51.58 | 58.70 | 54.54 | |
Free Cash Flow per Share |
12.26 | 11.94 | 11.21 | 11.08 | |
Free Cash Flow |
4,702.00 | 4,571.00 | 4,283.00 | 4,238.00 | |
Capital Expenditures |
(823.00) | (804.00) | (761.00) | (594.00) | |
| Other line items | |||||
Cash ROIC |
11.09% | 11.24% | 10.11% | 10.16% | |
Accounts Receivable Turnover |
6.75 | 6.71 | 6.26 | 6.61 | |
Accounts Payable Turnover |
5.83 | 5.98 | 5.20 | 6.19 | |
Inventory Turnover |
1.67 | 1.74 | 1.80 | 1.65 | |
Average Days of Payables |
67.08 | 63.58 | 72.55 | 62.35 | |
Days of Inventory on Hand |
222.69 | 216.43 | 214.14 | 223.49 | |
Tax Rate |
(0.28) | (0.27) | (0.28) | (0.12) | |
Research and Development Expense of Revenue |
6.42% | 6.45% | 6.46% | 6.48% | |
Selling, General and Administrative Expense of Revenue |
33.99% | 34.16% | 34.44% | 35.06% | |
Share Based Compensation of Revenue |
0.97% | 0.97% | 0.97% | 0.98% | |
Interest Coverage |
7.29 | 6.61 | 7.86 | — | |
Operating CF/Net income |
1.48 | 1.61 | 1.55 | 1.64 | |
Depreciation/Fixed assets |
0.31 | 0.31 | 0.31 | 0.31 | |
Capex/Depreciation |
(0.67) | (0.66) | (0.64) | (0.52) | |
Revenue per Share |
67.37 | 66.00 | 65.71 | 63.76 | |
Operating CF per Share |
14.41 | 14.04 | 13.20 | 12.64 | |
Capex per Share |
(2.15) | (2.10) | (1.99) | (1.55) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.02 |
Columns are period end dates